Matthew G Myers, Madison O Walsh, Kipling M Bohnert
{"title":"Disproportionate Increases in Daily Cannabis Use Among Adults with Co-Occurring Depression and Psychological Distress, 2005-2019.","authors":"Matthew G Myers, Madison O Walsh, Kipling M Bohnert","doi":"10.15288/jsad.25-00151","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prevalences and frequencies of cannabis use are increasing in the U.S., particularly among those with past-year major depressive episodes (MDE) or serious psychological distress (SPD). Relationships between comorbid MDE and SPD and past-year cannabis use, daily cannabis use, and cannabis use disorder are unexplored. Here, we compare trends (2005-2019) of cannabis use among U.S. adults with monomorbid, comorbid, or neither MDE nor SPD.</p><p><strong>Methods: </strong>We aggregated 2005 to 2019 National Survey on Drug Use and Health data (unweighted n=590,229). Using sociodemographic-adjusted logistic regressions, we estimated and compared the trends of past-year cannabis use, daily cannabis use, and cannabis use disorder (CUD) among U.S. adults with MDE, SPD, comorbid MDE and SPD, and neither MDE nor SPD. All results are nationally representative.</p><p><strong>Results: </strong>Individuals with MDE only, SPD only, and comorbid MDE and SPD had higher prevalences of past-year cannabis use, daily cannabis use, and CUD compared to those without MDE or SPD. Average yearly trends of past-year cannabis use increased universally but rose faster among those with MDE and/or SPD than among those without MDE or SPD. Those with comorbid MDE and SPD had the greatest increase in prevalence of daily cannabis use (327.7% from 2005 to 2019). We found no trends in CUD prevalences across all groups.</p><p><strong>Conclusions: </strong>Daily cannabis use has risen most rapidly among those with comorbid MDE and SPD, a population with potentially more complex and severe mental health symptomology. Public health efforts may need to address daily cannabis use among individuals with mental health conditions to reduce disparities.</p>","PeriodicalId":17159,"journal":{"name":"Journal of studies on alcohol and drugs","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of studies on alcohol and drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15288/jsad.25-00151","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Prevalences and frequencies of cannabis use are increasing in the U.S., particularly among those with past-year major depressive episodes (MDE) or serious psychological distress (SPD). Relationships between comorbid MDE and SPD and past-year cannabis use, daily cannabis use, and cannabis use disorder are unexplored. Here, we compare trends (2005-2019) of cannabis use among U.S. adults with monomorbid, comorbid, or neither MDE nor SPD.
Methods: We aggregated 2005 to 2019 National Survey on Drug Use and Health data (unweighted n=590,229). Using sociodemographic-adjusted logistic regressions, we estimated and compared the trends of past-year cannabis use, daily cannabis use, and cannabis use disorder (CUD) among U.S. adults with MDE, SPD, comorbid MDE and SPD, and neither MDE nor SPD. All results are nationally representative.
Results: Individuals with MDE only, SPD only, and comorbid MDE and SPD had higher prevalences of past-year cannabis use, daily cannabis use, and CUD compared to those without MDE or SPD. Average yearly trends of past-year cannabis use increased universally but rose faster among those with MDE and/or SPD than among those without MDE or SPD. Those with comorbid MDE and SPD had the greatest increase in prevalence of daily cannabis use (327.7% from 2005 to 2019). We found no trends in CUD prevalences across all groups.
Conclusions: Daily cannabis use has risen most rapidly among those with comorbid MDE and SPD, a population with potentially more complex and severe mental health symptomology. Public health efforts may need to address daily cannabis use among individuals with mental health conditions to reduce disparities.
期刊介绍：
The Journal of Studies on Alcohol and Drugs began in 1940 as the Quarterly Journal of Studies on Alcohol. It was founded by Howard W. Haggard, M.D., director of Yale University’s Laboratory of Applied Physiology. Dr. Haggard was a physiologist studying the effects of alcohol on the body, and he started the Journal as a way to publish the increasing amount of research on alcohol use, abuse, and treatment that emerged from Yale and other institutions in the years following the repeal of Prohibition in 1933. In addition to original research, the Journal also published abstracts summarizing other published documents dealing with alcohol. At Yale, Dr. Haggard built a large team of alcohol researchers within the Laboratory of Applied Physiology—including E.M. Jellinek, who became managing editor of the Journal in 1941. In 1943, to bring together the various alcohol research projects conducted by the Laboratory, Dr. Haggard formed the Section of Studies on Alcohol, which also became home to the Journal and its editorial staff. In 1950, the Section was renamed the Center of Alcohol Studies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
